Heart disease model puts cells to work
Researchers at Washington University can more effectively study mutations that cause heart disease by putting stem cells through their paces. Their research offers insight into the origins of hypertrophic cardiomyopathy.
Chen awarded two Scialog grants to study the molecular basis of cognition
Yao Chen, an assistant professor of neuroscience at the School of Medicine, is part of two teams that have been awarded grants to study the molecular processes that underlie memory and cognition.
‘You think, so you can dance’
In “The Neuroscience of Movement,” dancer and research scientist Elinor Harrison introduces students to the complex neural processes that allow us to coordinate thought, action and perception.
Cannabis use tied to increased risk of severe COVID-19
A study by researchers at Washington University School of Medicine in St. Louis shows that people with COVID-19 who used cannabis were more likely to be hospitalized and require intensive care than those who did not use the drug.
Social workers key to psychedelic-assisted therapies
As psychedelic-assisted therapy gains mainstream acceptance, the role of social workers, who provide a significant portion of mental health services in the United States, will become increasingly important in this emerging field, says an expert on mental health in the Brown School.
Modifying homes for stroke survivors saves lives, extends independence
Researchers at Washington University School of Medicine in St. Louis have found that safety interventions — such as walkers, grab bars, ramps and other home modifications — allow many stroke survivors to keep living independently in their homes and may reduce their risk of death.
New technology allows researchers to precisely, flexibly modulate brain
Researchers at Washington University have developed a noninvasive technology combining a holographic acoustic device with genetic engineering that allows them to precisely target affected neurons in the brain.
Repurposed drug may help stabilize vision in rare disease
In a new study, a team of researchers at Washington University School of Medicine in St. Louis reports that a drug approved by the FDA for another condition may stabilize vision for patients with RVCL-S, a rare genetic disease.
Study aims to understand genetics of Parkinson’s disease in Black people
School of Medicine researchers have joined an international study aimed at understanding the gene changes that may lead to Parkinson’s disease in Black and African American people.
Lucey receives sleep science award
Brendan P. Lucey, MD, a professor of neurology at the School of Medicine, has been awarded the 2024 Sleep Science Award from the American Academy of Neurology in recognition of his distinguished contributions to the neurology and neuroscience of sleep.
Older Stories